UAE introduces first-ever weight loss pill Foundayo, here’s how much it may cost and where to get it
The UAE has approved Foundayo (orforglipron), Eli Lilly's once-daily oral obesity pill, becoming one of the first countries globally to offer a needle-free alternative.
This GLP-1 receptor agonist mimics natural hormones to regulate appetite and blood sugar, aiding weight loss and improving metabolic health.
Available by prescription from May 2026, it's intended for long-term use alongside lifestyle changes.
Lilly's weight loss pill debut
- Lilly weight loss pill prescriptions said to near 1,400 in first week of launch Seeking Alpha —
- Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week - Reuters Reuters —
- GLP-1 developer Kailera prices IPO at $16 per share to raise $625M Seeking Alpha —
- Eli Lilly's CEO is ‘disappointed’ that only 1 in 10 Americans are on GLP-1s Semafor —